Last updated on February 2018

Testing the Efficiency of Karman Curette in the Treatment of Misoprostol Failure in Women With Missed Abortion


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Missed abortion
  • Age: Between 18 - 100 Years
  • Gender: Female

Inclusion Criteria:

  • Healthy women diagnosed with missed abortion treated in Meir Medical Center.
  • The abortion occured during the first trimester of pregnancy.
  • Patients who chose drug therapy (Misoprostol), after retained products of conception were evident on ultrasound.

Exclusion Criteria:

  • patients with mullarian abnormality (i.e. septal uterus, myoma etc.)
  • patients with significant bleeding
  • Endometrial wall (residua) greater than 20 mm.
  • known or suspected infection
  • known clotting defect
  • women after cesarean section
  • closed cervix

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.